To compare the efficacy and safety of single ( tamsulosin ) and double dose ( tamsulosin + alfuzosin ) alpha-blocker therapy for treating catheterized patients with acute urinary retention ( AUR ) due to benign prostatic hyperplasia ( BPH ) .